Disculpa, pero esta entrada está disponible sólo en English.
(English) Barbara Bush Foundation Partners with Barbershop Books and Penguin Young Readers to Provide Child-Friendly Reading Spaces in Baltimore and Detroit Barbershops
(English)
WASHINGTON, Aug. 3, 2020 /PRNewswire/ — The Barbara Bush Foundation for Family Literacy has partnered with Barbershop Books and Penguin Young Readers to provide child-friendly reading spaces and early literacy training to help expand reading opportunities for Black boys in Baltimore and Detroit.
(English) Bio-Techne And Kantaro Biosciences To Launch A Quantitative Research Use Only COVID-19 Serology Test
(English)
MINNEAPOLIS and NEW YORK, Aug. 3, 2020 /PRNewswire/ — Bio-Techne Corporation (NASDAQ:TECH) and the Mount Sinai Health System in New York, through its commercial affiliate Kantaro Biosciences LLC (Kantaro), today announced the anticipated launch of the COVID-SeroIndex, a Kantaro Quantitative SARS-CoV-2 IgG Antibody RUO kit. Bio-Techne and Kantaro will leverage a joint commercialization and distribution team to support rapid…
(English) Bio-Techne And Kantaro Biosciences To Launch A Quantitative Research Use Only COVID-19 Serology Test
(English)
MINNEAPOLIS and NEW YORK, Aug. 3, 2020 /PRNewswire/ — Bio-Techne Corporation (NASDAQ:TECH) and the Mount Sinai Health System in New York, through its commercial affiliate Kantaro Biosciences LLC (Kantaro), today announced the anticipated launch of the COVID-SeroIndex, a Kantaro Quantitative SARS-CoV-2 IgG Antibody RUO kit. Bio-Techne and Kantaro will leverage a joint commercialization and distribution team to support rapid…
(English) Joint Helmet Mounted Cueing System (JHMCS) II Undergoes Flight Testing Aboard F-16V
(English)
FORT WORTH, Texas, Aug. 3, 2020 /PRNewswire/ — JHMCS II, the newest member of the Joint Helmet Mounted Cueing System family of products, is being flight tested aboard the Lockheed Martin F-16V aircraft in the United States. This follows the completion of JHMCS II safety qualification testing, including windblast, tower and sled tests.
(English) Kadimastem Reports Positive Interim Results of Cohort B of its AstroRx® Phase 1/2a Clinical Trial in ALS
(English)
NESS ZIONA, Israel, Aug. 3, 2020 /PRNewswire/ — Kadimastem Ltd. (TASE: KDST), a clinical-stage biotechnology company developing cell therapies for the treatment of severe debilitating diseases, announced today that its lead product, AstroRx®, showed a positive efficacy signal and a good safety profile in Cohort B of the Company’s Phase 1/2a clinical trial in ALS.
(English) A Sweat-Free School Year: Dermadry Launches 2020 Scholarship For Students Who Sweat Too Much
(English)
MONTREAL , Aug. 3, 2020 /PRNewswire/ — Dermadry is back with the second annual edition of its scholarship. The contest is open to students from around the globe who suffer from
(English) FDA Accepts and Grants Priority Review of Vanda’s Applications for HETLIOZ® (tasimelteon) in the Treatment of Smith-Magenis Syndrome
(English)
WASHINGTON, Aug. 3, 2020 /PRNewswire/ — Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) has accepted for priority review Vanda’s applications for Smith-Magenis Syndrome (SMS). The applications include a Supplemental New Drug Application (sNDA) for HETLIOZ® capsules and a New Drug Application (NDA) for the liquid formulation of HETLIOZ® for the treatment of adults and children, respectively, with Smith-Magenis…
(English) BD releases FY 2019 Sustainability Report
(English)
FRANKLIN LAKES, N.J., Aug. 3, 2020 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued its 2019 Sustainability Report, focusing on performance of the environmental, social and governance factors that support the company’s
(English) BD releases FY 2019 Sustainability Report
(English)
FRANKLIN LAKES, N.J., Aug. 3, 2020 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued its 2019 Sustainability Report, focusing on performance of the environmental, social and governance factors that support the company’s
(English) Lannett Announces Launch Of FDA Approved Levothyroxine Tablets
(English)
PHILADELPHIA, Aug. 3, 2020 /PRNewswire/ — Lannett Company, Inc. (NYSE: LCI) today announced the launch of Cediprof, Inc.’s FDA approved Levothyroxine Sodium Tablets USP, under the companies recently announced interim exclusive supply and distribution agreement.